Home › Medical › CBD and Sleep
⚐ Flag an error How this page was made
Also known as: cannabidiol for insomnia · CBD sleep aid

CBD and Sleep

CBD may help anxiety-driven sleep loss, but the science for general insomnia is weak.

Automated fact-check pass
14 cited sources
Published
Last reviewed
How this page was made

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

↯ The honest take

CBD is heavily marketed for sleep, but it is not a proven standalone sleep aid. The strongest case is for anxiety-driven insomnia—racing thoughts keeping you awake. Even there, the evidence is modest and most studies are small. Many 'CBD sleep' products contain melatonin, CBN, or trace THC; those ingredients or placebo may do the real work. CBT-I (talking therapy) is better-proven for chronic insomnia. If you try CBD, get pure products tested by a third party, and tell your doctor—it blocks liver enzymes that metabolize many drugs.

Not Medical Advice

This article is for education only, not medical advice. Sleep problems can be symptoms of serious underlying conditions—sleep apnea, depression, thyroid dysfunction, medication side effects, or other medical disorders. Consult a clinician before self-treating with CBD, especially if you take other medications. CBD inhibits liver enzymes (CYP3A4, CYP2C19) and can raise blood levels of many drugs, including warfarin, certain anticonvulsants, and statins Strong evidence[1]. A pharmacist or doctor can assess your specific risk.

Plain-Language Summary

CBD (cannabidiol) is a non-intoxicating compound found in cannabis. People buy it for sleep, but the clinical evidence that pure CBD is a reliable sleep aid is weaker than marketing suggests. The strongest case is indirect: CBD may reduce anxiety, and if worry or racing thoughts are keeping you awake, less anxiety might help you sleep Weak / limited[2][3]. For straightforward insomnia in otherwise healthy adults, controlled trials are few and results are mixed Weak / limited[4].

Many products sold as 'CBD sleep aids' also contain melatonin, CBN (cannabinol), or trace THC—and those ingredients, plus the placebo effect and the context of self-care, likely account for much of the reported benefit Disputed[5]. Without controlling for these, it is hard to know how much CBD itself contributes.

If you have chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) is proven more effective than CBD and is recommended as first-line treatment by major sleep medicine bodies Strong evidence[6].

What Probably Works

No CBD sleep claim has reached 'strong evidence' status yet. The closest candidates are:

Anxiety-Driven Insomnia

A 2019 retrospective case series from a psychiatric clinic (n=72) found that 66.7% of patients given CBD (25–75 mg daily) reported improved sleep scores within the first month, although scores fluctuated over longer follow-up Weak / limited[2]. Importantly, many of these patients also had anxiety disorder as a primary diagnosis. The mechanism is likely: less anxiety → easier sleep onset.

A 2019 randomized controlled trial (n=24) found that 300 mg oral CBD reduced anxiety symptoms before a public-speaking task, supporting the anxiety-reduction pathway Weak / limited[3]. This does not prove CBD improves sleep, but anxiety reduction is the mechanism by which it might.

Seizure-Related Sleep Disruption in Rare Epilepsies

In Dravet syndrome and Lennox-Gastaut syndrome, treatment with pharmaceutical CBD (Epidiolex) improved sleep disruption secondarily to seizure reduction Strong evidence[7]. This is a specific medical context and does not generalize to healthy adults buying CBD gummies.

What Might Work

Evidence is limited or inconsistent for these applications:

What Doesn't Work or Has Weak Evidence

What We Don't Know

Comparison with Standard Treatments

Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I is the first-line treatment for chronic insomnia, recommended by the American College of Physicians, the American Academy of Sleep Medicine, and other professional bodies Strong evidence[6]. It is typically delivered over 6–8 weeks by a trained therapist and teaches sleep-restriction, stimulus control, cognitive restructuring, and sleep hygiene. Long-term studies show CBT-I outperforms sleep medications; benefits persist after treatment ends; and there are no side effects or dependence risk. No CBD study has been compared head-to-head against CBT-I.

Prescription Hypnotics (Benzodiazepines, Non-Benzodiazepine Sedatives)

Drugs like zolpidem (Ambien), eszopiclone (Lunesta), and suvorexant (Belsomra) have robust efficacy data: they reduce sleep-onset latency and improve total sleep time in short-term trials Strong evidence[6]. However, they carry risks: dependence (especially benzodiazepines), next-day cognitive impairment, complex sleep behaviors, and falls in older adults. CBD has not been rigorously compared to these drugs in head-to-head trials, so claims of a 'milder side-effect profile' lack direct evidence.

Melatonin

Melatonin has modest but well-replicated effects for circadian-rhythm sleep disorders (shift work, jet lag, delayed sleep-phase syndrome) and modest effects on sleep-onset latency Strong evidence[12]. For most chronic insomnia complaints, melatonin has stronger evidence than CBD and costs a fraction of the price. It is available over-the-counter and generally well-tolerated.

Bottom Line

For chronic insomnia: try CBT-I first. If medications are needed and CBT-I is unavailable or unsuccessful, melatonin has better evidence than CBD. If you explore CBD, it is best viewed as a potential adjunct for anxiety-driven sleep loss, not as a primary treatment.

Risks and Drug Interactions

CBD is generally well-tolerated but is not pharmacologically inert:

Drug Interactions

CBD inhibits two major liver enzymes: CYP3A4 and CYP2C19 Strong evidence[1][7]. This can raise blood levels of:

Always discuss CBD with your pharmacist or doctor if you take other medications, especially those with a narrow therapeutic window.

Hepatotoxicity

In high-dose epilepsy trials (up to 20 mg/kg/day), liver-enzyme elevations (alanine aminotransferase, aspartate aminotransferase) have been documented Strong evidence[7]. This is rare in typical sleep-dose ranges (25–75 mg), but long-term safety data are limited.

Common Side Effects

At higher doses, CBD can cause:

Product Quality and Mislabeling

Independent testing by cannabis analytics laboratories repeatedly finds commercial CBD products to be mislabeled: under-dosed, over-dosed, or containing undeclared THC Strong evidence[13]. A person using a product labeled '10 mg CBD' may receive 2–20 mg, or the product may contain enough THC to trigger a positive drug test. Buy from vendors who provide third-party lab reports (testing for CBD concentration, THC content, residual solvents, and microbial contaminants).

Pregnancy and Breastfeeding

The FDA advises against CBD use during pregnancy and breastfeeding Strong evidence[14]. Limited data exist on fetal or infant exposure; risks are not fully characterized.

Summary and Practical Guidance

Sources

  1. Peer-reviewed Brown JD, Winterstein AG. Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. J Clin Med. 2019;8(7):989.
  2. Peer-reviewed Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm J. 2019;23:18-041.
  3. Peer-reviewed Linares IM, Zuardi AW, Pereira LC, et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry. 2019;41(1):9-14.
  4. Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Curr Psychiatry Rep. 2017;19(4):23.
  5. Reported Grinspoon P. Cannabidiol (CBD) — what we know and what we don't. Harvard Health Publishing, Harvard Medical School. Updated 2024.
  6. Peer-reviewed Devinsky O, Cross JH, Laux L, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017;376(21):2011-2020.
  7. Peer-reviewed Chagas MH, Eckeli AL, Zuardi AW, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series. J Clin Pharm Ther. 2014;39(5):564-566.
  8. Peer-reviewed National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
  9. Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis Cannabinoid Res. 2016;1(1):44-46.
  10. Peer-reviewed Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol. J Pharm Pharmacol. 2004;56(3):291-297.
  11. Peer-reviewed Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165(2):125-133.
  12. Peer-reviewed Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.
  13. Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, et al. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017;318(17):1708-1709.
  14. Government U.S. Food and Drug Administration. What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding. FDA Consumer Updates. 2019.

How this page was made

Generation history

Oct 30, 2026
Revision
Oct 30, 2026
Fact-check pass — raised 8 flags
May 12, 2026
Fact-check pass — raised 3 flags
May 12, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.